Joseph Gligorov
- Oncology top 0.5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Jean Pierre LotzVincent Launay‐VacherJean‐François MorèreNicolas JanusHeikki JoensuuPhilippe BeuzebocStéphane OudardXavier Pourrat
- Topics
- Breast Cancer Treatment Studies (103 papers)HER2/EGFR in Cancer Research (100 papers)Cancer Treatment and Pharmacology (91 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- FranceSwitzerlandGermany
In The Last Decade
Joseph Gligorov
270 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 129
- Oncology 2.8k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 966
- Molecular Biology 859
- Radiology, Nuclear Medicine and Imaging 616
Countries citing papers authored by Joseph Gligorov
This map shows the geographic impact of Joseph Gligorov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Gligorov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Gligorov more than expected).
Fields of papers citing papers by Joseph Gligorov
This network shows the impact of papers produced by Joseph Gligorov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Gligorov. The network helps show where Joseph Gligorov may publish in the future.
Co-authorship network of co-authors of Joseph Gligorov
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Gligorov. A scholar is included among the top collaborators of Joseph Gligorov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Gligorov. Joseph Gligorov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 28 | |
| 7 | 3 | |
| 8 | 16 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 8 | |
| 12 | 2 | |
| 13 | 74 | |
| 14 | 1 | |
| 15 | 22 | |
| 16 | ABCB1 (MDR1) genotype in relation to doxorubicin and docetaxel pharmacokinetics in patients with breast cancer | 1 |
| 17 | 1 | |
| 18 | [HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]. | 3 |
| 19 | Point sur la prise en charge des métastases osseuses avec les bisphosphonates IV en cancérologie | 1 |
| 20 | [Dose density and dose intensity in the treatment of breast cancer]. | 4 |
About Joseph Gligorov
Joseph Gligorov is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 284 papers that have together received 4.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (103 papers), HER2/EGFR in Cancer Research (100 papers) and Cancer Treatment and Pharmacology (91 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (1.3k citations) and Pulmonary and Respiratory Medicine (966 citations). Joseph Gligorov has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Jean Pierre Lotz, Vincent Launay‐Vacher, Jean‐François Morère, Nicolas Janus, Heikki Joensuu, Philippe Beuzeboc, Stéphane Oudard, Xavier Pourrat, Jean‐Marc Nabholtz and Gilbert Deray. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.